{"id":"https://openalex.org/W4381893369","doi":"https://doi.org/10.1016/s0140-6736(23)01201-1","title":"Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists","display_name":"Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists","alternate_titles":[],"publication_year":2023,"publication_date":"2023-06-24","ids":{"openalex":"https://openalex.org/W4381893369","doi":"https://doi.org/10.1016/s0140-6736(23)01201-1","pmid":"https://pubmed.ncbi.nlm.nih.gov/37369233"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(23)01201-1","doi":"https://doi.org/10.1016/s0140-6736(23)01201-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(23)01201-1","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4381893369"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067359287","display_name":"Michael Albrecht Nauck","orcid":"https://orcid.org/0000-0002-5749-6954","observed_orcids":["https://orcid.org/0000-0002-5749-6954","https://orcid.org/0000-0003-2455-0472"]},"institutions":[{"id":"https://openalex.org/I2799318839","display_name":"Universit\u00e4tsmedizin Greifswald","ror":"https://ror.org/025vngs54","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799318839"]},{"id":"https://openalex.org/I4210138993","display_name":"St. Josef-Hospital","ror":"https://ror.org/046vare28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210138993","https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I4210153564","display_name":"Katholisches Klinikum Bochum","ror":"https://ror.org/05k5t2r42","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael A Nauck","raw_affiliation_strings":["Diabetes, Endocrinology, Metabolism Section, Medical Department I, St Josef Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum 44791, Germany; Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany. Electronic address: michael.nauck@rub.de","Diabetes, Endocrinology, Metabolism Section, Medical Department I, St Josef Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum 44791, Germany","Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes, Endocrinology, Metabolism Section, Medical Department I, St Josef Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum 44791, Germany; Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany. Electronic address: michael.nauck@rub.de","institution_ids":["https://openalex.org/I2799318839","https://openalex.org/I4210138993","https://openalex.org/I4210153564","https://openalex.org/I904495901"]},{"raw_affiliation_string":"Diabetes, Endocrinology, Metabolism Section, Medical Department I, St Josef Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum 44791, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I4210153564","https://openalex.org/I904495901"]},{"raw_affiliation_string":"Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I2799318839"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069463167","display_name":"Michael Horowitz","orcid":"https://orcid.org/0000-0002-0942-0306","observed_orcids":["https://orcid.org/0000-0002-0942-0306"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Horowitz","raw_affiliation_strings":["Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide and the Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide and the Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia","institution_ids":["https://openalex.org/I1320133117","https://openalex.org/I5681781"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5067359287"],"corresponding_institution_ids":["https://openalex.org/I2799318839","https://openalex.org/I4210138993","https://openalex.org/I4210153564","https://openalex.org/I904495901"],"apc_list":{"value":6830,"currency":"USD","value_usd":6830},"apc_paid":null,"fwci":2.6672,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.91251444,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"402","issue":"10400","first_page":"429","last_page":"431"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orforglipron","display_name":"orforglipron","score":0.9890000224113464},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.984000027179718},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8849999904632568},{"id":"https://openalex.org/keywords/oral-glp-1-receptor-agonists","display_name":"oral GLP-1 receptor agonists","score":0.8420000076293945},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.777999997138977},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9399999976158142},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.996999979019165},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":1.0},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8289999961853027},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7039999961853027},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.7860000133514404},{"id":"https://openalex.org/keywords/drug-competition","display_name":"drug competition","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9362571835517883},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.9243841767311096},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.8996886014938354},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8870725631713867},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.7594824433326721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6961943507194519},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5861305594444275},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.525769054889679},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4826691448688507},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43930381536483765},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4177325665950775},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41570010781288147},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3690859079360962},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.30159562826156616}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0140-6736(23)01201-1","doi":"https://doi.org/10.1016/s0140-6736(23)01201-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(23)01201-1","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:37369233","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37369233","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2081678747","https://openalex.org/W2099223875","https://openalex.org/W2766836053","https://openalex.org/W2792903930","https://openalex.org/W2916296804","https://openalex.org/W2951522032","https://openalex.org/W2979558564","https://openalex.org/W3093042356","https://openalex.org/W3099724881","https://openalex.org/W3166038843","https://openalex.org/W4297021616","https://openalex.org/W4381885429"],"related_works":["https://openalex.org/W2786247186","https://openalex.org/W2979558564","https://openalex.org/W3131762509","https://openalex.org/W2257678016","https://openalex.org/W2023891261","https://openalex.org/W4391544038","https://openalex.org/W3093042356","https://openalex.org/W3024880155","https://openalex.org/W3114382483","https://openalex.org/W7154685041"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4381893369","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2023-06-25T00:00:00"}
